Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials

被引：0
|
作者：
Chris J Bushe
Nicola C Savill
机构：
[1] Lilly House,Eli Lilly and Company Ltd
来源：
Child and Adolescent Psychiatry and Mental Health | / 7卷
关键词：
ADHD; Suicide-related events; Summary of product characteristics; Systematic review; Atomoxetine; Methylphenidate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials
    Wehmeier P.M.
    Schacht A.
    Escobar R.
    Savill N.
    Harpin V.
    Child and Adolescent Psychiatry and Mental Health, 4 (1)
  • [32] Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
    Ribeiro, Johanne Pereira
    Arthur, Emma Jasmine
    Gluud, Christian
    Simonsen, Erik
    Storebo, Ole Jakob
    PEDIATRIC REPORTS, 2021, 13 (03): : 434 - 443
  • [33] Effectiveness and Tolerability of Methylphenidate in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Bodey, Caroline
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 353 - 363
  • [34] A meta-analysis on the effect of telemedicine on the management of attention deficit and hyperactivity disorder in children and adolescents
    Bemanalizadeh, Maryam
    Yazdi, Maryam
    Yaghini, Omid
    Kelishadi, Roya
    JOURNAL OF TELEMEDICINE AND TELECARE, 2024, 30 (01) : 31 - 43
  • [35] A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder
    Fabiano, Gregory A.
    Pelham, William E., Jr.
    Coles, Erika K.
    Gnagy, Elizabeth M.
    Chronis-Tuscano, Andrea
    O'Connor, Briannon C.
    CLINICAL PSYCHOLOGY REVIEW, 2009, 29 (02) : 129 - 140
  • [36] Efficacy of Attention Deficit Hyperactivity Disorder treatments in children and adolescents
    Jarque Fernandez, Sonia
    ANUARIO DE PSICOLOGIA, 2012, 42 (01): : 19 - U134
  • [37] Atomoxetine:: a new treatment for attention deficit/hyperactivity disorder (ADHD) in children and adolescents
    Purper-Ouakil, D
    Fourneret, P
    Wohl, M
    Rénéric, JP
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2005, 31 (03): : 337 - 348
  • [38] Efficacy and safety of atomoxetine in the treatment of attention deficit/hyperactivity disorder in children and adolescents
    Brown, WJ
    Biederman, J
    Spencer, T
    Heiligenstein, J
    Wernicke, J
    Allen, AJ
    Faries, D
    Michelson, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S411 - S411
  • [39] Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Kohn, Michael R.
    Tsang, Tracey W.
    Clarke, Simon D.
    CLINICAL MEDICINE INSIGHTS-PEDIATRICS, 2012, 6 : 95 - 162
  • [40] Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
    Hammerness, Paul
    McCarthy, Katherine
    Mancuso, Elizabeth
    Gendron, Cassandra
    Geller, Daniel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 215 - 226
12345